Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75p -4.91% 14.525p 14.40p 14.65p 14.70p 14.50p 14.55p 735,802 16:35:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 54.00

Circassia Pharmaceuticals Share Discussion Threads

Showing 1201 to 1224 of 1225 messages
Chat Pages: 49  48  47  46  45  44  43  42  41  40  39  38  Older
DateSubjectAuthorDiscuss
21/6/2019
20:31
Filtered? Lol, I will never follow you and that’s a fact.
turvart
21/6/2019
20:18
Filtered! always asking the abbot for his advice and opinion, something escape never does. He leads others follow.
escapetohome
21/6/2019
18:05
The Abbot, Are you still holding or you flat?
turvart
21/6/2019
08:37
Way overdone is my take. Some short term turbulance perhaps, but once it clears, its take off. Book your ticket. Hee hee.
escapetohome
19/6/2019
12:50
Go on put an offer in. Theyve done all the hard work for you, then slipped up with their cosy relationship with woody, allowing YOU to go in low. Put in an offer + 30 %. Ill take it.
escapetohome
19/6/2019
09:03
Who is running the slide rule over this? At this price one or two perhaps All the hard works done for them. SNAP IT UP IT MAKES SENSE.
escapetohome
18/6/2019
22:52
Buy go you knoW IT.
escapetohome
18/6/2019
22:52
Why should woody sell his illiquid shares if more redemptions? I would argue it would be the liquid ones he would sell. The illiquid are far too oversold now, and no market. Very vey very very strong buy here.
escapetohome
18/6/2019
17:48
This bad share yeugh yeugh. I vomit
volsung
18/6/2019
17:45
The only thing that worries me about buying into this is how many additional listings will they need to fund the future growth and what sort of dilution could take place, I personally don’t see it a strong buy at the moment. It could be a strong buy once revenue is flowing nicely and we know what sort of shares are going to be in issue, this may have a lot more to drop yet and even if it goes to 5p, what sort of quantity of shares are we looking at it future? I might be very wrong I might be right, but do you see my point?
turvart
18/6/2019
15:31
Anthony Cross, the uber-successful British fund manager, who oversees the Liontrust Special Situations fund, once opined that, "When it comes to investing, what is comfortable is rarely profitable."
researchanalyst1
18/6/2019
12:54
Strong buy id say. Im in ARE YOU?
escapetohome
18/6/2019
12:52
AstraZeneca owns 20 % of this company? Why?
escapetohome
18/6/2019
08:56
Im in folks. Strong buy now!
escapetohome
18/6/2019
08:00
Why would somebody buy 250000 shares..40,000 pounds Abbott? Somebody recognises a ridiculously under valued stock even if you don't...and they are right.
maybesum
18/6/2019
07:57
They do have the $120m+ debt, so I sold at £150 loss. GLA
cantrememberthis2
18/6/2019
06:11
Yes, and therein lies the conundrum. Why exactly is the price being subject to such downward pressure? We know soemone's selling and I suspect shorting as well but is it because Woodford is once again slicing his holding or is there something fundamentally wrong with the company? Or is it both? My feeling is that this is Woodford and shorting (all Woodford associated stocks being targeted)
gersemi
17/6/2019
23:31
Oh dear ! Is this one of woodys better picks? Well done woody!
escapetohome
17/6/2019
22:53
And you have no way of knowing the sells were stop losses....wishful thinking perhaps, or people just had enough.
the abbot
17/6/2019
22:52
Yes, with all that said and the company being so so undervalued, do you see the directors that know more than anything about how the company os performing or what its future is buying any shares, no you do not...why not? As much as you think it is undervalued, this is one very very sharp falling knife and one I would only try to catch once it has stopped, todays selling only shows and increase is downward speed. Again I call for people to sit up and listen to what is ACTUALLY happening not what they hope will or should happen, in any business that has failed so dramatically to protect its shareholders only one course of action is to be deemed acceptable, that is, fire the CEO WITHOUT a golden goodbye. He IS the one that happily stood by and provided free shares to directors at £0.0008 and allowed them to immediately sell them into the market, what message did that send to the investors a message sanctioned by a failing and failed CEO, incompetent is only one word but sums him up nicely, promoted above his competence is another.
the abbot
17/6/2019
19:06
Rathean, you're spot on. Beginning on May 06 2019 – when the share price was 31.05p – Circassia has suffered a rare capitulation that is wholly disconnected to its fundamentals. Selling cascaded to extremes as stop losses were sequentially triggered, battering this junior pharma to exceedingly low levels. While very challenging psychologically, capitulations are super-bullish. They rapidly exhaust all near-term selling potential, leaving stocks wildly oversold and undervalued which, in turn, ushers in major new uplegs. The word capitulation, after all, means ‘the act of surrendering or giving up’. That’s exactly what’s happened in this extraordinary selling event; investors simply bolted for the exits. Exceptionally-bearish investor sentiment hit the company following grossly exaggerated rumours of a gargantuan fire sale by Woodford which proved to be wholly unfounded. In the end, WIM only sold 4% of its 28.03% stake to stand at 24.47% on June 06 2019 whilst Invesco and St James hoovered-up the dirt cheap shares albeit with a miniscule reduction from Invesco thereafter. And since then, on June 10 2019, Woodford has come out to re-assure investors that his fire sale is well and truly done after raising £500m to fulfil outstanding redemptions. Http://www.morningstar.co.uk/uk/news/AN_1560170000672276500/woodford-raises-gbp500-million-from-flurry-of-london-share-sales-%28alliss%29.aspx Thus, my point is, the stock is now grossly oversold on the following grounds: Circassia’s market cap is currently £60.9m (16.25p). Less cash and cash equivalents of £40.34m means the market is valuing Duaklir®, Tudorza®, NIOX®, and AirNOvent at £20.6m! Seriously? Does anyone out there really believe that Duaklir®, Tudorza®, NIOX®, and AirNOvent are collectively worth £20.6m? For crying out loud, the company’s audited value of its net assets, as stated in its May 01 2019 final results, stood at £125.9 million! Thus, it is vacuous nonsense to suggest that Duaklir®, Tudorza®, NIOX®, and AirNOvent are collectively worth £20m when their 2019 forecasted revenues are in excess of £74m! Yes, Circassia is on track to materially increase NIOX® revenues in China following the implementation of direct sales in the country, Tudorza® revenues following the exercise of the option at the end of 2018, and Duaklir® revenues following the product's approval by the FDA at the end of March. Thus, as far as gross undervaluations go, Circassia Pharma is off the scale. That being said, the negative sentiment appears to have finally petered out with the share price hitting an all-time low of 16.10p in the last half hour of trading, following a flurry of stop losses, before closing up at 16.25p (the true closing price not the UT price). To this end, disregard the ‘noise’ and take cue from the 250k buy that went through at the ridiculous price of 16.30p. I call it smart money. .
researchanalyst1
17/6/2019
15:48
Did you see all those Directors buys...oh no of course not that would mean using their own money for shares. Steve Harris, Circassia how has he not been sacked, incompetance in the extreme. In control of a shareprice decline from £3.55 to 16p
the abbot
17/6/2019
10:25
Did you mean to say that out loud? Nothing wrong with this business, two huge pots selling into an already oversold stock, keep some shekels on the sidelines for the inevitable capitulation imo dyor ofc.
rathean
16/6/2019
16:24
buywell does not like this
buywell3
Chat Pages: 49  48  47  46  45  44  43  42  41  40  39  38  Older
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190627 02:17:56